Selective inhibitor of p38 mitogen-activated protein kinase inhibits lipopolysaccharide-induced interleukin-8 expression in human pulmonary vascular endothelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 370-375

  Hashimoto, Shu ^a   Gon, Yasuhiro ^a   Matsumoto, Ken ^a   Maruoka, Shuichiro ^a   Takeshita, Ikuko ^a   Hayashi, Shinichi ^a   Asai, Yasukiyo ^a   Asai, Yoshito ^a   Jibiki, Itsuro ^a   Machino, Tatsuya ^a   Horie, Takashi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PULMONARY ARTERY; PYRIDINES; RNA, MESSENGER;

EID: 0034053791     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL and Griswold DE (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461.
2. Baggiolini M, Dewald B and Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179.
3. Bernard G, Artigas A, Brigham KL, Carlet J, Falke K, Hudson, L, Lamy M, Legall R, Morris A, Spragg, R and the Consensus Committee (1994) The American-European consensus conference on ARDS, definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am Rev Respir Dis 149:818-824.
4. Brett SJ, Hansell DM and Evans TW (1998) Clinical correlationin acute lung injury, response to inhaled nitric oxide. Chest 114:1397-1404.
5. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett 364:229-233.
6. Davis RJ (1994) MAPKs: New JNK expand the group. Trends Biochem Sci 19:470-473.
7. Hashimoto S and Horie T (1994) Adult respiratory distress syndrome and adhesion molecules, in Basic and Clinical Aspects of Pulmonary Fibrosis (Takishima T ed) pp 433-443, CRC Press, Boca Raton, FL.
8. Hashimoto S, Matsumoto K, Gon Y, Maruoka S, Takeshita I, Hayashi S, Koura T, Kujime K and Horie T (1999a) p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells. Eur Respir J 13:1357-1364.
9. Hashimoto S, Matsumoto K, Gon Y, Nakayama T, Takeshita I and Horie T (1999b) Hyperosmolarity-induced IL-8 expression in human bronchial epithelial cells through p38 MAP kinase-dependent pathway. Am J Respir Crit Care Med 159: 634-640.
10. Hogg JC (1987) Neutrophil kinetics and lung injury. Physiol Rev 67:1249-1294.
11. Huber AR, Kunkel SL, Todd RF III and Weiss SJ (1991) Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science (Wash DC) 254:99-102.
12. Hyers TM, Tricomi SM, Dettrnmeier PA and Fouler A (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144:268-271.
13. Idell S, Kucich U, Fein A, Kueppers F, James HL, Walssh PN, Weinbaum G, Colman RW and Cohen AB (1985) Neutrophil elastase-releasing factor in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132:1098-1105.
14. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kummer S, Green D, McNulthy D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemen IR, Fisher SM, Livi GP, White JR, Adams JL and Young P (1994) A protein kinase involved in the regulation of inflammtory cytokine biosynthesis. Nature (Lond) 372:739-746.
15. Manthey CL, Wang SW, Kinney SD and Yao Z (1998) SB 202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64:409-417.
16. Mantovani A and Dejana E (1989) Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10:370-375.
17. Matsumoto K, Hashimoto S, Gon Y, Nakayama T and Horie T (1998) Proinflammatory cytokine- and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 MAP kinase-dependent pathway. J Allergy Clin Immunol 101:825-831.
18. Matsumoto T, Yokoi K, Mukaida N, Harada A, Yamashita J, Watanabe Y and Matsushima K (1997) Pivotal role of interluekin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J Leukoc Biol 62:581-587.
19. Matthay MA (1990) The adult respiratory distress syndrome, definition and prognosis. Clin Chest Med 11:575-580.
20. Mauder CJ, Hackman RC, Riff E, Albert K and Springmeyer SC (1986) Occurrence of the adult respiratory distress syndrome in neutropenic patients. Am Rev Respir Dis 133:313-316.
21. Meduri GU (1996) The role of the host defence response in the progression and outcome of ARDS: Pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 9:2659-2670.
22. Meduri GU, Kohler G, Headley S, Tolley E, Stents F and Postlethwaite A (1995) Inflammatory cytokines in the BAL of patients with ARDS, persistent elevation over time predicts poor outcome. Chest 108:1303-1314.
23. Metz S and Sibbald WJ (1991) Anti-inflammatory therapy of acute lung injury, a review of animal and clinical studies. Chest 100:1110-1119.
24. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E and Mattay MA (1992) Elevated levels of NAP-1/interleukin-8 are present in the airspace of patients with adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146:427-432.
25. Mukaida N, Matsumoto T, Yokoi K, Harada A and Matsushima K (1998) Inhibition of neutrophil-mediated acute lung inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res 47:S151-S157.
26. Mukaida M, Shiroo M and Matsushima K (1989) Genomic structure of the human monocytederived neutrophil chemotactic factor IL-8. J Immunol 143:1366-1371.
27. Nogare NRD (1989) Adult respiratory distress syndrome. Am J Med Sci 298:413-431.
28. Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch JC, Shelhamer H and Parrillo JE (1986) Adult respiratory distress syndrome in patients with severe neutropenia. New Engl J Med 315:547-551.
29. Pugin J, Ricou B, Steinberg KP, Suter PM and Martin TR (1996) Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 152:1850-1856.
30. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch and R Davis (1995) Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
31. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P, Karawajew L and Herrmann F (1996) Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood 87:2805-2814.
32. Shapiro L and Dinarello (1995) Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92:12230-12234.
33. Strieter RM, Kunkel SL, Showell HJ, Remik DG, Phan SH, Wards PA and Mark RM (1989) Endothelial cell gene expression of a neutrophil chemotatic factor by TNF-α, LPS, and IL1. Science (Wash DC) 243:1467-1469.
34. Tagan MC, Markert M, Schaller MD, Feihl F, Chiolero ZR and Claude CH (1991) Oxidative metabolism of circulating granulocytes in adult respiratory distress syndrome. Am J Med 91:S72-S78.
35. Tate RM and Repine JE (1983) Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128:552-559.
36. Thomas PS (1983) Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods Enzymol 100:255-266.
37. Young PR, McLaughlin MM, Kumar S, Kassi S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnel PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL and Lee JC (1997) Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 272:12116-12121.
38. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM and Gadek JE (1986) Lung neutrophils in the adult respiratory distress syndrome, clinical and pathophysiological significance. Am Rev Respir Dis 133:218-225.
39. Zimmerman GA, Renzetti AD and Hill HR (1983) Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Am Rev Respir Dis 127:290-300.